Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

[The dome dogma].

Go back to Resources

[The dome dogma].

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

The safety and efficacy of chicken type II collagen on uveitis associated with juvenile rheumatoid arthritis.

Go back to Resources

The safety and efficacy of chicken type II collagen on uveitis associated with juvenile rheumatoid arthritis.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

BK virus nephropathy in pediatric renal transplant recipients: an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry.

Go back to Resources

BK virus nephropathy in pediatric renal transplant recipients: an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

A problem with synthetic maps.

Go back to Resources

A problem with synthetic maps.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Abstract:

Go back to Resources

A new protocol for evaluating putative causes for multiple variables in a spatial setting, illustrated by its application to European cancer rates.

Go back to Resources

A new protocol for evaluating putative causes for multiple variables in a spatial setting, illustrated by its application to European cancer rates.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Timing and characteristics of multiple peritonitis episodes: a report of the National CAPD Registry.

Go back to Resources

Timing and characteristics of multiple peritonitis episodes: a report of the National CAPD Registry.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Therapeutic synergism.

Go back to Resources

Therapeutic synergism.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

Survival analysis of drug combinations using a hazards model with time-dependent covariates.

Go back to Resources

Survival analysis of drug combinations using a hazards model with time-dependent covariates.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Abstract:

Go back to Resources

Statistical methods for determining prognosis in severe head injury.

Go back to Resources

Statistical methods for determining prognosis in severe head injury.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Abstract:

Go back to Resources

Statistical aspects of intraperitoneal chemotherapy studies.

Go back to Resources

Statistical aspects of intraperitoneal chemotherapy studies.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Current page 29
  • Page 30
  • Page 31
  • Page 32
  • Page 33
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • ISO Certification